These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Amyloid arthropathy and Waldenström macroglobulinemia. Gisserot O; Landais C; Cremades S; Terrier JP; Leyral G; Bernard P; de Jauréguiberry JP Joint Bone Spine; 2006 Jul; 73(4):456-8. PubMed ID: 16087379 [TBL] [Abstract][Full Text] [Related]
29. A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia. Ghobrial IM; Vij R; Siegel D; Badros A; Kaufman J; Raje N; Jakubowiak A; Savona MR; Obreja M; Berdeja JG Clin Cancer Res; 2019 Aug; 25(16):4907-4916. PubMed ID: 31142508 [TBL] [Abstract][Full Text] [Related]
30. Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214). Treon SP; Meid K; Tripsas C; Heffner LT; Eradat H; Badros AZ; Xu L; Hunter ZR; Yang G; Patterson CJ; Gustine J; Castillo JJ; Matous J; Ghobrial IM Clin Cancer Res; 2017 May; 23(10):2400-2404. PubMed ID: 27836860 [No Abstract] [Full Text] [Related]
31. Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO). Simon L; Fitsiori A; Lemal R; Dupuis J; Carpentier B; Boudin L; Corby A; Aurran-Schleinitz T; Gastaud L; Talbot A; Leprêtre S; Mahe B; Payet C; Soussain C; Bonnet C; Vincent L; Lissandre S; Herbrecht R; Kremer S; Leblond V; Fornecker LM Haematologica; 2015 Dec; 100(12):1587-94. PubMed ID: 26385211 [TBL] [Abstract][Full Text] [Related]
32. [Association between motoneuron disease and Waldenström macroglobulinemia]. Di Saverio A; Quaglino D Recenti Prog Med; 2001 Sep; 92(9):530-2. PubMed ID: 11552308 [TBL] [Abstract][Full Text] [Related]
33. [Recurrence of Waldenström macroglobulinemia accompanied by factor X deficiency]. Ohara S; Hagihara M; Hua J; Inoue M; Uchida T; Yoshinaga T; Yazaki M; Sekijima Y; Kametani F Rinsho Ketsueki; 2016 Mar; 57(3):359-63. PubMed ID: 27076250 [TBL] [Abstract][Full Text] [Related]
34. Waldenström macroglobulinemia: my way. Gertz M Leuk Lymphoma; 2013 Mar; 54(3):464-71. PubMed ID: 22860921 [TBL] [Abstract][Full Text] [Related]
35. Biclonal lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with POEMS syndrome: A case report and literature review. Wang Q; Liu Q; Liang H; Gao W Oncol Lett; 2023 Mar; 25(3):97. PubMed ID: 36817054 [TBL] [Abstract][Full Text] [Related]
36. [Waldenström macroglobulinemia associated with cutaneous lesions and type I cryoglobulinemia]. del Olmo J; España A; Idoate MA; Panizo C Actas Dermosifiliogr; 2008 Mar; 99(2):138-44. PubMed ID: 18346436 [TBL] [Abstract][Full Text] [Related]
37. Ibrutinib in the management of Waldenstrom macroglobulinemia. Yosef A; Touloukian EZ; Nambudiri VE J Oncol Pharm Pract; 2019 Mar; 25(2):434-441. PubMed ID: 29996737 [TBL] [Abstract][Full Text] [Related]
38. Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis. Merlini G; Sarosiek S; Benevolo G; Cao X; Dimopoulos M; Garcia-Sanz R; Gatt ME; Fernandez de Larrea C; San-Miguel J; Treon SP; Minnema MC Semin Hematol; 2023 Mar; 60(2):113-117. PubMed ID: 37099030 [TBL] [Abstract][Full Text] [Related]
39. Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemia. Kawano Y; Nakama T; Hata H; Kimura E; Maruyoshi N; Uchino M; Mitsuya H J Neurol Sci; 2010 Oct; 297(1-2):101-4. PubMed ID: 20673674 [TBL] [Abstract][Full Text] [Related]
40. New insights into the pathogenesis and treatment of Waldenstrom macroglobulinemia. Issa GC; Leblebjian H; Roccaro AM; Ghobrial IM Curr Opin Hematol; 2011 Jul; 18(4):260-5. PubMed ID: 21519243 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]